Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.

Lien MoreelAlbrecht BetrainsLennert BoeckxstaensGeert MolenberghsKoen Van LaereEllen De LangheSteven VanderschuerenDaniel Blockmans

Published in: Seminars in arthritis and rheumatism (2024)

GCA patients with PMR symptoms had more recalcitrant disease with a higher risk of relapse and longer duration of GC treatment with need for higher GC doses.

Keyphrases

giant cell
physical activity
sleep quality
depressive symptoms
mass spectrometry
combination therapy
simultaneous determination